# Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms

> **NCT07013890** · PHASE4 · COMPLETED · sponsor: **Clinica Urologica Molinette - Città della Saliute e della Scienza** · enrollment: 48 (actual)

## Conditions studied

- Chronic Prostatitis (CP)
- Chronic Prostatitis With Chronic Pelvic Pain Syndrome
- Chronic Prostatitis/ Pelvic Pain Syndrome

## Interventions

- **DRUG:** FICOXPEA® is an oral combination of Phycocyanin, Palmitoylethanolamide and selenium

## Key facts

- **NCT ID:** NCT07013890
- **Lead sponsor:** Clinica Urologica Molinette - Città della Saliute e della Scienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-02
- **Primary completion:** 2023-08-15
- **Final completion:** 2023-09-30
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-07-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07013890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07013890, "Efficacy of Phycocyanin and Palmitoylethanolamide for the Treatment of Chronic Prostatitis Symptoms". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07013890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*